Clinical Trials on Hypotension, Orthostatic in New Zealand

Total 1041 results

Icahn School of Medicine at Mount Sinai
AT&T and Vital Tech

Suspended

Telehealth Referral to Improve Outcomes (TRIO)

Hypertension

United States
PhaseBio Pharmaceuticals Inc.

Terminated

Long-Term, Open Label Extension Study of Pemziviptadil (PB1046) in PAH Subjects Following Completion of Study PB1046-PT-CL-0004 (VIP Extend)

Pulmonary Arterial Hypertension

United States
Novartis

Completed

Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Hypertensive Patients

Hypertension

United States, Germany
Solvay Pharmaceuticals

Completed

Efficacy and Safety of Moxonidine in Indian Patients

Hypertension

India
Aria CV, Inc

Recruiting

Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System (ASPIRE PH)

Pulmonary Arterial Hypertension | Pulmonary Hypertension | Right Heart Dysfunction

United States
Aerie Pharmaceuticals

Completed

AR-12286 in Combination With Latanoprost

Ocular Hypertension | Glaucoma

United States
Govind Ballabh Pant Hospital

Completed

A Trial of Somatostatin With Endoscopic Variceal Ligation (EVL) in Control of Acute Variceal Bleeding (AVB-EVL+S)

Cirrhosis | Portal Hypertension | Acute Bleeding Esophageal Varices

India
Bayer

Completed

Measuring Outcomes In Patients With Pulmonary Arterial Hypertension Not on Active Treatment (MOTION)

Hypertension, Pulmonary

United States, Puerto Rico
United Therapeutics

Completed

Tyvaso Dosing and Titration Evaluation: TyTRATE Registry

Pulmonary Arterial Hypertension

United States, Puerto Rico
Symplmed Pharmaceuticals LLC

Completed

Perindopril Amlodipine for the Treatment of Hypertension (PATH)

Essential Hypertension

United States
Gilead Sciences

Completed

Study of Ambrisentan in Participants With Pulmonary Hypertension (ABS-LT)

Pulmonary Hypertension

United States, Australia, Argentina, Canada, Mexico, Brazil, Chile, Russian Federation, Ukraine
Gilead Sciences

Completed

Safety and Efficacy Study of Ambrisentan in Subjects With Pulmonary Hypertension

Pulmonary Hypertension

United States, Canada, Australia
University of Rochester
National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...

Recruiting

Team-Based Home Blood Pressure Monitoring (TB-HBPM)

Hypertension | High Blood Pressure

United States
United Therapeutics

Withdrawn

FREEDOM DR: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor or as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)

Pulmonary Hypertension

United States, Australia, Mexico
GlaxoSmithKline

Completed

A Study to Compare COREG CR to COREG CR Fixed-dose Combination in Patients With High Blood Pressure

Hypertension

United States
Vascular Dynamics, Inc.

Completed

Controlling and Lowering Blood Pressure With The MOBIUSHD™ (CALM-FIM_US)

Hypertension

United States
University of Rochester

Terminated

Effects of High Caffeine Content Coffee on Blood Pressure in Young Adults

High Blood Pressure

United States
United Therapeutics

Completed

EXPEDITE: A Study of Remodulin Induction Followed by Orenitram Optimization to Treat Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension

United States
Northwell Health
GE Healthcare

Withdrawn

The Role of Echocardiographic Contrast (Optison) in Enhancing Tricuspid Regurgitation Spectral Doppler Signals

Hypertension, Pulmonary

United States
Santen Inc.

Completed

Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension

Open-angle Glaucoma or Ocular Hypertension

United States
The New York Eye Surgery Center
Ocular Therapeutix, Inc.

Terminated

Prospective Study on DEXTENZA® Safety And Efficacy Following Concomitant MIGS and Cataract Surgery (SUSTAIN)

Glaucoma | Cataract

United States
Allergan

Completed

Safety and Efficacy of Three Formulations of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution

Ocular Hypertension | Glaucoma, Open-Angle

United States
United Therapeutics
Lung Biotechnology PBC

Completed

Patient Global Impression Questions for Activity-Induced Symptoms in Participants With PAH (PRN)

Pulmonary Arterial Hypertension

United States
Acceleron Pharma Inc. (a wholly owned subsidiary...

Completed

A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH) (PULSAR)

Pulmonary Arterial Hypertension

Spain, United States, Israel, Australia, Germany, United Kingdom, France, Brazil
Actelion

Completed

Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States (OrPHeUS)

Pulmonary Arterial Hypertension

United States, Puerto Rico
New York City Department of Health and Mental Hygiene
NYU Langone Health; Robert Wood Johnson Foundation; Riverdale Family Practice... and other collaborators

Completed

Evaluation of Integrating Self Blood Pressure Monitoring Into Urban Primary Care Practices (ESBPM)

Hypertension | Cardiovascular Disease

United States
Aerie Pharmaceuticals

Completed

AR-12286 Fixed Dose Combination to Lower Elevated Intraocular Pressure

Ocular Hypertension | Glaucoma

United States
Novartis

Completed

To Find Out Whether Valsartan With or Without Other Blood Pressure Medications Would Improve the Ability of the Heart to Fill and Empty, and the Ability of the Heart Muscle to Relax Adequately in People With High Blood Pressure.

Hypertension | Diastolic Dysfunction

United States
Novartis

Completed

A Study Of Valsartan Used To Treat Hypertension For Up To 13 Months In Hypertensive Children Ages 6 - 16 Years Of Age

Hypertension

Germany, United States
Novartis Pharmaceuticals
Baker Heart and Diabetes Institute

Completed

Valsartan Intensified Primary Care Reduction of Blood Pressure Study (VIPER-BP)

Hypertension

United States, Australia
Synvista Therapeutics, Inc

Terminated

Systolic Pressure Efficacy and Safety Trial of Alagebrium (SPECTRA)

Hypertension

United States
Takeda

Completed

Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Moderate to Severe Hypertension.

Essential Hypertension

United States, Canada
State University of New York at Buffalo

Completed

24 Hour Ambulatory Cardiac Oxygen Consumption

Hypertension

United States
Novartis

Completed

Tolerability, Safety and Efficacy of RKI983 Eye Drops in Subjects With Primary Open Angle Glaucoma and Ocular Hypertension

Ocular Hypertension | Glaucoma

United States
NicOx

Completed

To Assess the Effect of Naproxcinod Versus Naproxen and Ibuprofen on Arterial Blood Pressure in Osteoarthritis Patients With Controlled Essential Hypertension (HCT3012-X-112)

Hypertension | Osteoarthritis

United States
Pfizer

Terminated

A Long-Term, Open-Label Study to Evaluate the Safety of Sitaxsentan Sodium Treatment in Patients With Pulmonary Arterial Hypertension (STRIDE-3)

Pulmonary Arterial Hypertension

United States, Netherlands, Canada, Belgium, France, Germany, Italy, Spain, United Kingdom, Australia, Poland, Austria, Brazil, Israel, Argentina, Mexico
Tulane University
National Institute of General Medical Sciences (NIGMS); LA CaTS Clinical Research...

Completed

Text My Hypertension BP Meds NOLA

Hypertension

United States
United Therapeutics

Completed

Open-label, Clinical Study to Evaluate the Safety and Tolerability of TreT in Subjects With PAH Currently Using Tyvaso (BREEZE)

Pulmonary Arterial Hypertension

United States
Pfizer

Terminated

A Study Of Different Doses Of TBC3711 In Patients With Uncontrolled High Blood Pressure Already Taking Medications For High Blood Pressure.

Resistant Hypertension

United States
AstraZeneca

Completed

Atacand Dose Range Finding Study in Pediatric Subjects 6 to <17 Years of Age

Pediatric Hypertension

United States, Hungary, Slovakia, Belgium
West-Ward Pharmaceutical

Recruiting

Study to Determine the Pharmacokinetics and Pharmacodynamic Effects of Phenylephrine on BP Via IV

Hypotension

United States
Lung Biotechnology PBC

Completed

Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients

Pulmonary Arterial Hypertension

United States, Belgium, Czechia, Germany, Ireland, Romania
Santen Inc.

Completed

Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open-Angle Glaucoma

United States
Boehringer Ingelheim

Completed

Telmisartan/Amlodipine (80/10) vs. Telmisartan/Amlodipine (40/10) vs. amlodipine10 in Resistant Hypertension

Hypertension

Australia, Austria, Bulgaria, Czech Republic, Ireland, Italy, New Zealand, Russian Federation, Slovakia, Spain, Switzerland, Turkey, Ukraine, United Kingdom
Actelion

Completed

OPsumit USers Registry (OPUS)

Pulmonary Arterial Hypertension

United States, Puerto Rico
Tulane University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Implementation of Multifaceted Patient-Centered Treatment Strategies for Intensive Blood Pressure Control (IMPACTS) (IMPACTS)

Hypertension | Blood Pressure

United States
Ocuphire Pharma, Inc.

Completed

Safety and Efficacy of Ophthalmic Phentolamine Mesylate in Glaucoma

Ocular Hypertension | Open Angle Glaucoma

United States
SoniVie Inc.

Active, not recruiting

REDUCED 1 - Renal Denervation Using Ultrasonic Catheter EmitteD Energy Study / (REDUCED)

Uncontrolled Stage 2 Hypertension

United States
NYU Langone Health
Columbia University; New York City Health and Hospitals Corporation; Hebrew Home...

Completed

Practice-based Trial of Blood Pressure Control in African Americans (TLC-Clinic)

Hypertension | Physical Activity | Medication Adherence | Diet

United States
Takeda

Completed

Efficacy and Safety of Azilsartan Medoxomil in African American Participants With Essential Hypertension

Hypertension

United States, Puerto Rico

Clinical Trials on Hypotension, Orthostatic in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burundi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations